Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 May 23.
Published in final edited form as: Biochem Biophys Res Commun. 2014 Oct 1;453(3):467–472. doi: 10.1016/j.bbrc.2014.09.109

bantam miRNA is important for Drosophila blood cell homeostasis and a regulator of proliferation in the hematopoietic progenitor niche

Victoria Lam a, Tsuyoshi Tokusumi a, Yumiko Tokusumi a, Robert A Schulz a,*
PMCID: PMC5964997  NIHMSID: NIHMS634347  PMID: 25280996

Abstract

The Drosophila hematopoietic system is utilized in this study to gain novel insights into the process of growth control of the hematopoietic progenitor niche in blood development. The niche microenvironment is an essential component controlling the balance between progenitor populations and differentiated, mature blood cells and has been shown to lead to hematopoietic malignancies in humans when misregulated. MicroRNAs are one class of regulators associated with blood malignancies; however, there remains a relative paucity of information about the role of miRNAs in the niche. Here we demonstrate that bantam miRNA is endogenously active in the Drosophila hematopoietic progenitor niche, the posterior signaling center (PSC), and functions in the primary hematopoietic organ, the lymph gland, as a positive regulator of growth. Loss of bantam leads to a significant reduction in the PSC and overall lymph gland size, as well as a loss of the progenitor population and correlative premature differentiation of mature hemocytes. Interestingly, in addition to being essential for proper lymph gland development, we have determined bantam to be a novel upstream component of the insulin signaling cascade in the PSC and have unveiled dMyc as one factor central to bantam activity. These important findings identify bantam as a new hematopoietic regulator, place it in an evolutionarily conserved signaling pathway, present one way in which it is regulated, and provide a mechanism through which it facilitates cellular proliferation in the hematopoietic niche.

Keywords: bantam miRNA, Drosophila, hematopoietic stem cell-like niche, hematopoiesis, InR pathway signaling, Myc

1. Introduction

The cellular organization and molecular signaling that occurs in Drosophila hematopoiesis strikingly parallels that which is seen in the hematopoietic stem cell niches of vertebrate animals, including several mammals [1-3]. An elegant example of such similarity is the recent discovery of the Drosophila hematopoietic progenitor niche which like its vertebrate counterpart, uses homologous signaling pathways for hematopoietic progenitor maintenance [4-8]. The primary hematopoietic organ, the lymph gland, is comprised of three morphologically and molecularly distinct compartments: (1) the posterior signaling center (PSC), which is the stem cell-like niche, (2) the medullary zone comprised of self-renewing hematopoietic progenitors, that eventually undergo progressive differentiation into the increasingly lineage restricted mature blood cells of (3) the cortical zone which directly surrounds the medullary zone. Cells of the PSC are specified by the homeotic gene Antennapedia (Antp) and maintained by the Drosophila ortholog of vertebrate Early B-cell Factor: Collier (Col) [6,9]. Regulatory signals, such as Hedgehog (Hh), emanate from the PSC in a non-cell-autonomous manner to preserve the progenitor population of the medullary zone [5,6,10]. In lymph glands lacking a PSC or that do not express hh, there is depletion of the progenitor population and concomitant, premature differentiation of mature hemocytes.

This emphasizes the essential role of this cellular domain in controlling the vital balance between proliferation of progenitors and lineage commitment to mature blood cells. It is thus of fundamental importance to elucidate the signals that govern maintenance of the PSC [4-6, 11-14].

Several reports have detailed key contributions by miRNAs in regulating the development of specific hematopoietic lineages [15-20]. Furthermore there is evidence of their causative role in mediating malignant diseases in the hematopoietic system [21-24]. Owing to their important developmental roles and ability to target known oncogenes and tumor suppressors, miRNAs are a key part of the intricate molecular networks that drive or suppress cancer development and progression [16]. However, despite their clear relationship with hematopoietic development and cancer, there remains a paucity of knowledge regarding the expression patterns, the identity of their target genes, and in vivo function of miRNAs in hematopoietic stem cell (HSC) populations and their niches [25-27]. Since both uncontrolled HSC expansion as well as loss of HSC is deleterious for humans, an understanding of the molecular mechanisms of HSC fate decision is thus of considerable importance.

In this study, we investigate the role of bantam miRNA, in hematopoiesis and elucidate its relationship with the Insulin-like receptor (InR) pathway and dMyc in positively regulating growth [28-30]. The InR pathway is a critical, conserved pathway responsible for regulating cell size and number in Drosophila [31-33]. Previous studies have shown that InR pathway signaling impacts PSC size and maintenance of the blood progenitor population [34-38]. Similarly dMyc, the Drosophila transcriptional activator orthologous to the mammalian proto-oncoprotein c-Myc, has also been shown to be an important positive regulator of growth in the PSC [35,39-41]. Our studies present a novel role for this crucial miRNA specifically in regulating the hematopoietic niche through interacting with these signaling factors established to be essential in controlling growth and proliferation.

2. Materials and methods

2.1. Fly stocks

We used the following lines in this study: P85col-Gal4 (col-Gal4) (M. Crozatier) [5,9]; hhF4f-GFP [14]; bantam sensor GFP, control sensor, UAS-bantam-A, bantamΔ1 and UAS-dsRed bantam sponge (S. Cohen) [28,42]; UAS-myr∷tdTomato, UAS-InR, UAS-dMyc, UAS-dMyc RNAi (TRiP JF1761), UAS-foxo, and w1118 obtained from the Bloomington Stock Center and UAS-Akt1 RNAi (GD1361) obtained from the Vienna Drosophila RNAi Center. Flies were reared on a conventional cornmeal-based medium. Egg-lays were done at 25°C and the lymph glands of 5-days old (unless otherwise indicated) 3rd instar larvae were dissected. As a consequence of the delayed developmental timeframe of bantamΔ1 homozygous null mutants, due in part to reduced growth rates, all larvae analyzed were 7-days old and kept at 29°C for purposes of keeping comparative analysis consistent [29].

2.2. Immunostaining

Immunostaining was performed as described previously [14]. The following primary antibodies were used to determine protein expression in lymph glands dissected from control or mutant animals: mouse anti-plasmatocyte (P1) antibody (1:100) [43,44] and mouse anti-Antp antibody (1:100; 4C3, Developmental Studies Hybridoma Bank) [6]. As secondary antibodies, we used Alexa 488 or 555-conjugated mouse IgG antibodies (Invitrogen). Cell nuclei are stained with 4′, 6-diamidino-2-phenylindole (DAPI). Samples were analyzed and imaged with a Zeiss Axioplan 2 fluorescence microscope or a Nikon A1R-NP laser-scanning confocal microscope.

2.3. Counting PSC cell number

A minimum of twenty, individual lymph glands were analyzed for each genotype. Statistical analyses of Antp-positive cell counts were performed as previously described [45] and analyzed with a t-test.

3. Results and Discussion

3.1. bantam miRNA is an essential regulator of growth in the PSC and blood cell homeostasis in the lymph gland

Extensive studies have been conducted to determine the functions and interactions of signaling pathways in regulating the larval hematopoietic organ. However, it is not currently known whether miRNAs are involved in PSC development. We were specifically interested in investigating the impact of bantam miRNA, a known positive regulator of growth in Drosophila, on the hematopoietic system [28,30,46-48].

Directed overexpression of bantam, through utilizing the PSC-specific collier-Gal4 driver (col-Gal4), accelerated cell proliferation and was sufficient to cause significant overgrowth of the niche. This quadrupling of niche cells lead to a corresponding increase in the size of the hemocyte progenitor population of the medullary zone and an observed reduction in mature, P1-positive plasmatocytes in the cortical zone (Fig. 1B).

Fig. 1. Characterization of bantam miRNA expression and function in the PSC of the lymph gland.

Fig. 1

Anti-Antp staining and hhF4f-GFP transgene expression mark the PSC. Mature plasmatocytes are labeled with P1 staining and cell nuclei are stained with DAPI. (A) Wild type (wt) control lymph gland w1118 showing normal PSC size. (B) PSC specific overexpression of bantam, through col-GAL4. (C, D) lymph glands from bantamΔ1 homozygotes. (E) col-driven expression of a bantam sponge-dsRed transgene. (F) region of endogenous bantam activity indicated by loss of GFP expression in bantam sensor GFP background (empty arrowhead). (G) Anti-Antp staining indicates that the observed region of endogenous bantam activity occurs in the cells of the PSC (arrowhead). (H) Lymph gland expressing control sensor transgene express GFP due to insensitivity to bantam activity (empty arrowhead) (I) Region verified as PSC with anti-Antp staining (arrowhead) (J, K) col-driven bantam in bantam sensor GFP background. (J) Region of bantam activity (empty arrowhead) verified as (K) expanded PSC by anti-Antp staining (arrowhead). (L, M) Loss of bantam, in bantamΔ1 homozygous null mutants. (N) Statistical analysis of PSC cells in loss of function and gain of function of bantam.

In contrast, in homozygous null mutants (bantamΔ1) (Fig. 1C) and reduction of endogenous bantam through targeted expression of the bantam sponge-transgene (Fig. 1E), there is a significantly diminished to absent PSC [42,49,50]. Accordingly due to this decrease in number of PSC cells, there was also a substantial decrease of the instructive hh signal, as measured by the expression of hhF4f-GFP transgene, necessary for maintenance of the medullary zone (Fig. 1E). PSCs of bantam loss of function mutants had an average of just 2.75 PSC cells compared with 37 in control lymph glands (Fig. 1N). Reduction of the PSC culminated in a concomitant depletion of hematopoietic progenitors in the medullary zone and the swelling of the lymph gland with differentiated blood cells (Fig. 1D). This suggests that basal activity of bantam is specifically necessary for proper development of the PSC.

To verify both the location and expression levels of endogenous bantam miRNA in the lymph gland, we utilized a bantam sensor GFP transgene, comprised of a ubiquitously-active tubulin promoter driving the expression of a GFP gene with two perfect bantam target sequences located in the 3′UTR [28]. Cells without bantam activity remain fluorescent; however, in cells in which bantam miRNA is present, GFP mRNA is bound by bantam miRNA and degraded. Efficacy of this tool is demonstrated with a control transgene (control GFP) lacking any bantam target sequences in the 3′UTR, and thus is insensitive to bantam miRNA activity and shows no reduction in GFP (Fig. 1H, I). We used this as a means to demonstrate that bantam is indeed endogenously expressed in the lymph gland (empty arrowhead Fig. 1F) and confirmed, through labeling with anti-Antp antibody, that bantam miRNA expression is specific to the hematopoietic progenitor niche (arrowhead Fig. 1G). As a comparison, col-Gal4 driven bantam overexpression leads to substantial GFP reduction in the expanded cell population (Fig. 1J), which is indicative of increased bantam activity in the PSC (Fig. 1K). It was postulated that with the loss of bantam, GFP levels would not be reduced. However, due to the substantial reduction in PSC cell number in bantam null lymph glands, it was difficult to ascertain whether GFP levels changed in the remaining niche cells (Fig. 1L, M).

Together, these pieces of evidence indicate that bantam is an essential component in regulating hematopoietic homeostasis and a critical factor for proper PSC maintenance at endogenous levels. Furthermore, this implies that unlike many miRNAs that operate in slightly modulating or fine-tuning expression of target genes, and whose loss or overexpression only subtly impact cellular phenotypes, bantam function in the primary hematopoietic organ is both necessary for proper lymph gland size, development of the PSC, and general homeostasis during blood development and is sufficient for driving substantial proliferation in the niche.

3.2. bantam is dependent on Akt activity to positively regulate proliferation in the PSC

The InR pathway is a critical pathway responsible for regulating cell size and number in Drosophila and is evolutionarily conserved as a global regulator of growth in mammals [31-33,51,52]. Previous studies have shown that InR pathway signaling impacts PSC size and maintenance of the blood progenitor population [34-38]. The dominant-negative and RNAi analysis of positive regulators of growth within the InR pathway resulted in greatly diminished niches, a phenotype strikingly similar to that of PSCs in a bantam null background [35]. This led us to investigate a potential interaction between bantam and the InR pathway.

When InR is overexpressed in the PSC, it causes massive expansion (Fig. 2B) a phenotype that persists in the absence of bantam (Fig. 2C). This suggests that bantam may be an upstream regulator of the InR pathway specifically in the hematopoietic niche, thus providing a mechanism through which bantam promotes growth in the blood system.

Fig 2. Relationship between bantam and InR pathway components.

Fig 2

The PSC is marked by hhF4F-GFP, UAS-myr∷tdTomato or anti-Antp staining. (A) wt lymph gland. The following assays were conducted using the PSC-specific col-GAL4 driver: (B) UAS- InR, (C) bantam mutant and UAS-InR, (D) UAS-Akt1 RNAi, (E) UAS-Akt1 RNAi and UAS-bantam, (F) UAS-foxo, (G) UAS-foxo and UAS-bantam. (H) Quantification of the number of Antp-positive PSC cells in 5-days old larvae. (*, **, ***) indicate significant difference in respective pairwise comparisons.

For supporting evidence of this notion, we investigated two additional downstream components of the insulin signaling cascade: forkhead-related transcription factor (Foxo) and the antagonistic modulator of Foxo, the serine/threonine protein kinase Akt1 [53,54]. Foxo is the singular Drosophila ortholog of mammalian foxo, which functions in growth inhibition in response to reduced insulin signaling, through positively regulating cell death factors and growth-suppressors and inhibitors of cell cycle [53,54]. Expression of foxo in the niche resulted in significant reduction of both hhF4f-GFP and Antp-positive PSC cells (Fig. 2F). When both bantam and foxo are co-expressed in the PSC (Fig. 2G), foxo expression offsets the effects of proliferation-permissive bantam miRNA [55]. The overgrowth seen with bantam alone is lost with the niche exhibiting no significant difference in average Antp-positive cell number compared with wildtype (Fig. 2A, H).

Consistent with previous findings, loss of growth factor Akt1 in the PSC, through Akt1 RNAi expression, leads to a significant reduction in niche cell number (Fig. 2D) [35]. Additionally, despite concurrent expression of bantam, the loss of Akt1 also leads to a loss of PSC expansion (Fig. 2E), thus suggesting that bantam-induced overgrowth is reliant on Akt1 activity. Taken together we observed that bantam-induced overgrowth is abrogated by both the loss of positive regulator of growth, Akt1, and overexpression of negative regulator of growth, Foxo, both of which are key components of the InR pathway. Statistically identical outcomes of reduced Antp-positive PSCs, for both overexpression of Akt1 RNAi as well as co-expression of Akt1 RNAi and bantam, suggest that bantam is upstream of Akt1 and dependent on activation of the InR pathway to facilitate proliferation. Furthermore, consistent with bantam being upstream of this established growth-regulatory pathway, overexpression of InR is sufficient to rescue the effects of the loss of bantam (Fig. 2C).

3.3. bantam is dependent on dMyc to facilitate cell proliferation in the niche

dMyc has been extensively studied as a positive regulator of cell growth and the activator of genes responsible for DNA replication and progression through from G1 to S-phase [56-58]. It has been shown that dMyc is also an important growth regulator in the PSC and we have confirmed that the InR pathway positively regulates dMyc [39]. Building upon this model, we have recently determined that dMyc activity is promoted through InR pathway interaction with the Bag of marbles (bam)/Retinoblastoma-family protein (Rbf) pathway, which regulates genes important for mitotic G1-S phase progression. [Tokusumi et al., submitted].

Consistent with this, overexpression of dMyc in the PSC causes an expansion similar to that of bantam overexpression (Fig. 3A, A′, 1B). Additionally all of these PSC cells display bantam activity (Fig. 3A), which led us to investigate whether bantam and dMyc interact in the niche to promote proliferation. Our bantam sensor results indicated that endogenous bantam activity is significantly reduced with dMyc RNAi (Fig. 3B, B′). Further evidence, consistent with bantam reliance on dMyc to facilitate proliferation, is that the size of the niche (normally expanded to several hundred cells with bantam overexpression) becomes statistically identical to wild type (Fig. 3D), due to the loss of dMyc regardless of persistent bantam expression. These cells also expressed hhF4f-GFP suggesting functional production of the hh signal (data not shown). bantam miRNA operates in a permissive capacity in alleviating the repression of cell proliferation by targeting inhibitors of growth, however, for growth to take place, positive regulators of growth must also be present. These results can thus be interpreted as limited PSC cell number ultimately due to missing dMyc despite active inhibition of negative regulators by bantam.

Fig. 3. Bantam is dependent on dMyc for positively regulating proliferation in the PSC.

Fig. 3

PSC cells are marked by anti-Antp staining or UAS-myr∷tdTomato in the niche cells. (A, A′) bantam sensor in col-Gal4>dMyc background. (B, B′) bantam sensor in col-GAL4>UAS-dMyc RNAi. (B) Empty arrowhead marks lack of change in GFP in the PSC (B′) as indicated by col>myr∷tdTomato (arrowhead). (C) col-GAL4>UAS-bantam>UAS-dMycRNAi. (D) Quantificaton of Antp-positive PSC cells in 5-days old larvae (E) Proposed model for placement of bantam in the InR pathway in regulation of the hematopoietic niche.

We draw from this evidence that bantam-induced PSC expansion is in part dependent on dMyc activity, as loss of dMyc restricts the extent of bantam-induced niche expansion (Fig. 3C) and negatively impacts endogenous bantam activity (Fig. 3B, B′). Taken together, these results suggest that dMyc is a crucial positive regulator of bantam in the lymph gland, a stipulation that is additionally supported by overexpression of dMyc causing a net increase in bantam activity (Fig. 3A, A′). Overall the result is a signal-enhancing, positive feedback loop, in which bantam indirectly promotes growth through the InR cascade, which leads to dMyc activation and in turn, upregulation of bantam activity (Fig. 3E).

In summary, our studies demonstrate the direct role of bantam miRNA in the normal maintenance of pluripotent hematopoietic progenitors and how deregulation of this vital miRNA causes either overproliferation of blood cells or loss of vital hematopoietic populations. These findings not only identify a novel role for bantam in the lymph gland and unveil a new level complexity to the well-characterized function of bantam in growth control, but also broaden our understanding of how miRNAs contribute to blood cell development and malignant blood cell disorders.

Highlights.

  • bantam miRNA is endogenously expressed in the hematopoietic progenitor niche.

  • bantam is necessary and sufficient to induce cellular proliferation in the PSC.

  • bantam is upstream of the Insulin Receptor signaling pathway.

  • A model for positive regulation of hematopoietic niche growth is proposed.

Acknowledgments

We thank Drs. I. Ando, M. Crozatier, S. Cohen and various stock centers for antibodies and Drosophila strains. We also appreciate the Notre Dame Integrated Imaging Facility for use of confocal microscopes. This work was supported by grants to R.A.S. from the NIH (HL071540) and the Notre Dame Initiative in Adult Stem Cell Research.

Abbreviations

PSC

posterior signaling center

Antp

Antennapedia

Col

Collier

Hh

Hedgehog

HSC

hematopoietic stem cell

InR

Insulin-like receptor

col-Gal4

P85col-Gal4

Foxo

forkhead-related transcription factor

bam

Bag of marbles

Rbf

Retinoblastoma-family protein

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Orkin SH, Zon LI. Hematopoiesis: An evolving paradigm for stem cell biology. Cell. 2008;132(4):631–644. doi: 10.1016/j.cell.2008.01.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Martinez-Agosto JA, Mikkola HK, Hartenstein V, Banerjee U. The hematopoietic stem cell and its niche: A comparative view. Genes Dev. 2007;21(23):3044–3060. doi: 10.1101/gad.1602607. [DOI] [PubMed] [Google Scholar]
  • 3.Gering M, Patient R. Hedgehog signaling is required for adult blood stem cell formation in zebrafish embryos. Dev Cell. 2005;8(3):389–400. doi: 10.1016/j.devcel.2005.01.010. [DOI] [PubMed] [Google Scholar]
  • 4.Crozatier M, Meister M. Drosophila haematopoiesis. Cell Microbiol. 2007;9(5):1117–1126. doi: 10.1111/j.1462-5822.2007.00930.x. [DOI] [PubMed] [Google Scholar]
  • 5.Krzemien J, Dubois L, Makki R, Meister M, Vincent A, Crozatier M. Control of blood cell homeostasis in drosophila larvae by the posterior signalling centre. Nature. 2007;446(7133):325–328. doi: 10.1038/nature05650. [DOI] [PubMed] [Google Scholar]
  • 6.Mandal L, Martinez-Agosto JA, Evans CJ, Hartenstein V, Banerjee U. A hedgehog-and antennapedia-dependent niche maintains drosophila haematopoietic precursors. Nature. 2007;446(7133):320–324. doi: 10.1038/nature05585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Koch U, Radtke F. Haematopoietic stem cell niche in drosophila. Bioessays. 2007;29(8):713–716. doi: 10.1002/bies.20613. [DOI] [PubMed] [Google Scholar]
  • 8.Evans CJ, Hartenstein V, Banerjee U. Thicker than blood: Conserved mechanisms in drosophila and vertebrate hematopoiesis. Dev Cell. 2003;5(5):673–690. doi: 10.1016/s1534-5807(03)00335-6. [DOI] [PubMed] [Google Scholar]
  • 9.Crozatier M, Ubeda JM, Vincent A, Meister M. Cellular immune response to parasitization in drosophila requires the EBF orthologue collier. PLoS Biol. 2004;2(8):E196. doi: 10.1371/journal.pbio.0020196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Li L, Xie T. Stem cell niche: Structure and function. Annu Rev Cell Dev Biol. 2005;21:605–631. doi: 10.1146/annurev.cellbio.21.012704.131525. [DOI] [PubMed] [Google Scholar]
  • 11.Morrison SJ, Spradling AC. Stem cells and niches: Mechanisms that promote stem cell maintenance throughout life. Cell. 2008;132(4):598–611. doi: 10.1016/j.cell.2008.01.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Scadden DT. The stem-cell niche as an entity of action. Nature. 2006;441(7097):1075–1079. doi: 10.1038/nature04957. [DOI] [PubMed] [Google Scholar]
  • 13.Caussinus E, Hirth F. Asymmetric stem cell division in development and cancer. Prog Mol Subcell Biol. 2007;45:205–225. doi: 10.1007/978-3-540-69161-7_9. [DOI] [PubMed] [Google Scholar]
  • 14.Tokusumi Y, Tokusumi T, Stoller-Conrad J, Schulz RA. Serpent, suppressor of hairless and U-shaped are crucial regulators of hedgehog niche expression and prohemocyte maintenance during drosophila larval hematopoiesis. Development. 2010;137(21):3561–3568. doi: 10.1242/dev.053728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Vasilatou D, Papageorgiou S, Pappa V, Papageorgiou E, Dervenoulas J. The role of microRNAs in normal and malignant hematopoiesis. Eur J Haematol. 2010;84(1):1–16. doi: 10.1111/j.1600-0609.2009.01348.x. [DOI] [PubMed] [Google Scholar]
  • 16.O'Connell RM, Chaudhuri AA, Rao DS, Gibson WS, Balazs AB, Baltimore D. MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output. Proc Natl Acad Sci U S A. 2010;107(32):14235–14240. doi: 10.1073/pnas.1009798107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Chen CZ, Lodish HF. MicroRNAs as regulators of mammalian hematopoiesis. Semin Immunol. 2005;17(2):155–165. doi: 10.1016/j.smim.2005.01.001. [DOI] [PubMed] [Google Scholar]
  • 18.Garzon R, Garofalo M, Martelli MP, et al. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci U S A. 2008;105(10):3945–3950. doi: 10.1073/pnas.0800135105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Chen JF, Mandel EM, Thomson JM, et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet. 2006;38(2):228–233. doi: 10.1038/ng1725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Lodish HF, Zhou B, Liu G, Chen CZ. Micromanagement of the immune system by microRNAs. Nat Rev Immunol. 2008;8(2):120–130. doi: 10.1038/nri2252. [DOI] [PubMed] [Google Scholar]
  • 21.Lynam-Lennon N, Maher SG, Reynolds JV. The roles of microRNA in cancer and apoptosis. Biol Rev Camb Philos Soc. 2009;84(1):55–71. doi: 10.1111/j.1469-185X.2008.00061.x. [DOI] [PubMed] [Google Scholar]
  • 22.O'Connell RM, Rao DS, Chaudhuri AA, et al. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med. 2008;205(3):585–594. doi: 10.1084/jem.20072108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Han YC, Park CY, Bhagat G, et al. microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J Exp Med. 2010;207(3):475–489. doi: 10.1084/jem.20090831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Klein U, Dalla-Favera R. New insights into the pathogenesis of chronic lymphocytic leukemia. Semin Cancer Biol. 2010 doi: 10.1016/j.semcancer.2010.10.012. [DOI] [PubMed] [Google Scholar]
  • 25.Spizzo R, Nicoloso MS, Croce CM, Calin GA. SnapShot: MicroRNAs in cancer. Cell. 2009;137(3):586–586.e1. doi: 10.1016/j.cell.2009.04.040. [DOI] [PubMed] [Google Scholar]
  • 26.Ruan K, Fang X, Ouyang G. MicroRNAs: Novel regulators in the hallmarks of human cancer. Cancer Lett. 2009;285(2):116–126. doi: 10.1016/j.canlet.2009.04.031. [DOI] [PubMed] [Google Scholar]
  • 27.Drakaki A, Iliopoulos D. MicroRNA gene networks in oncogenesis. Curr Genomics. 2009;10(1):35–41. doi: 10.2174/138920209787581299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM. Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in drosophila. Cell. 2003;113(1):25–36. doi: 10.1016/s0092-8674(03)00231-9. [DOI] [PubMed] [Google Scholar]
  • 29.Boulan L, Martin D, Milan M. Bantam miRNA promotes systemic growth by connecting insulin signaling and ecdysone production. Curr Biol. 2013;23(6):473–478. doi: 10.1016/j.cub.2013.01.072. [DOI] [PubMed] [Google Scholar]
  • 30.Hipfner DR, Weigmann K, Cohen SM. The bantam gene regulates drosophila growth. Genetics. 2002;161(4):1527–1537. doi: 10.1093/genetics/161.4.1527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Edgar BA. How flies get their size: Genetics meets physiology. Nat Rev Genet. 2006;7(12):907–916. doi: 10.1038/nrg1989. [DOI] [PubMed] [Google Scholar]
  • 32.Taguchi A, White MF. Insulin-like signaling, nutrient homeostasis, and life span. Annu Rev Physiol. 2008;70:191–212. doi: 10.1146/annurev.physiol.70.113006.100533. [DOI] [PubMed] [Google Scholar]
  • 33.Wu Q, Brown MR. Signaling and function of insulin-like peptides in insects. Annu Rev Entomol. 2006;51:1–24. doi: 10.1146/annurev.ento.51.110104.151011. [DOI] [PubMed] [Google Scholar]
  • 34.Benmimoun B, Polesello C, Waltzer L, Haenlin M. Dual role for insulin/TOR signaling in the control of hematopoietic progenitor maintenance in drosophila. Development. 2012;139(10):1713–1717. doi: 10.1242/dev.080259. [DOI] [PubMed] [Google Scholar]
  • 35.Tokusumi Y, Tokusumi T, Shoue DA, Schulz RA. Gene regulatory networks controlling hematopoietic progenitor niche cell production and differentiation in the drosophila lymph gland. PLoS One. 2012;7(7):e41604. doi: 10.1371/journal.pone.0041604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Shim J, Mukherjee T, Banerjee U. Direct sensing of systemic and nutritional signals by haematopoietic progenitors in drosophila. Nat Cell Biol. 2012;14(4):394–400. doi: 10.1038/ncb2453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Dragojlovic-Munther M, Martinez-Agosto JA. Multifaceted roles of PTEN and TSC orchestrate growth and differentiation of drosophila blood progenitors. Development. 2012;139(20):3752–3763. doi: 10.1242/dev.074203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Shim J, Gururaja-Rao S, Banerjee U. Nutritional regulation of stem and progenitor cells in drosophila. Development. 2013;140(23):4647–4656. doi: 10.1242/dev.079087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Pennetier D, Oyallon J, Morin-Poulard I, Dejean S, Vincent A, Crozatier M. Size control of the drosophila hematopoietic niche by bone morphogenetic protein signaling reveals parallels with mammals. Proc Natl Acad Sci U S A. 2012;109(9):3389–3394. doi: 10.1073/pnas.1109407109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Gallant P, Shiio Y, Cheng PF, Parkhurst SM, Eisenman RN. Myc and max homologs in drosophila. Science. 1996;274(5292):1523–1527. doi: 10.1126/science.274.5292.1523. [DOI] [PubMed] [Google Scholar]
  • 41.Johnston LA, Prober DA, Edgar BA, Eisenman RN, Gallant P. Drosophila myc regulates cellular growth during development. Cell. 1999;98(6):779–790. doi: 10.1016/s0092-8674(00)81512-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Becam I, Rafel N, Hong X, Cohen SM, Milan M. Notch-mediated repression of bantam miRNA contributes to boundary formation in the drosophila wing. Development. 2011;138(17):3781–3789. doi: 10.1242/dev.064774. [DOI] [PubMed] [Google Scholar]
  • 43.Vilmos P, Nagy I, Kurucz E, Hultmark D, Gateff E, Ando I. A rapid rosetting method for separation of hemocyte sub-populations of drosophila melanogaster. Dev Comp Immunol. 2004;28(6):555–563. doi: 10.1016/j.dci.2003.10.001. [DOI] [PubMed] [Google Scholar]
  • 44.Asha H, Nagy I, Kovacs G, Stetson D, Ando I, Dearolf CR. Analysis of ras-induced overproliferation in drosophila hemocytes. Genetics. 2003;163(1):203–215. doi: 10.1093/genetics/163.1.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Sorrentino RP, Tokusumi T, Schulz RA. The friend of GATA protein U-shaped functions as a hematopoietic tumor suppressor in drosophila. Dev Biol. 2007;311(2):311–323. doi: 10.1016/j.ydbio.2007.08.011. [DOI] [PubMed] [Google Scholar]
  • 46.Huang H, Li J, Hu L, et al. Bantam is essential for drosophila intestinal stem cell proliferation in response to hippo signaling. Dev Biol. 2014;385(2):211–219. doi: 10.1016/j.ydbio.2013.11.008. [DOI] [PubMed] [Google Scholar]
  • 47.Zhang W, Cohen SM. The hippo pathway acts via p53 and microRNAs to control proliferation and proapoptotic gene expression during tissue growth. Biol Open. 2013;2(8):822–828. doi: 10.1242/bio.20134317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Zhang X, Luo D, Pflugfelder GO, Shen J. Dpp signaling inhibits proliferation in the drosophila wing by omb-dependent regional control of bantam. Development. 2013;140(14):2917–2922. doi: 10.1242/dev.094300. [DOI] [PubMed] [Google Scholar]
  • 49.Herranz H, Hong X, Cohen SM. Mutual repression by bantam miRNA and capicua links the EGFR/MAPK and hippo pathways in growth control. Curr Biol. 2012;22(8):651–657. doi: 10.1016/j.cub.2012.02.050. [DOI] [PubMed] [Google Scholar]
  • 50.Thompson BJ, Cohen SM. The hippo pathway regulates the bantam microRNA to control cell proliferation and apoptosis in drosophila. Cell. 2006;126(4):767–774. doi: 10.1016/j.cell.2006.07.013. [DOI] [PubMed] [Google Scholar]
  • 51.Galagovsky D, Katz MJ, Acevedo JM, Sorianello E, Glavic A, Wappner P. The drosophila insulin-degrading enzyme restricts growth by modulating the PI3K pathway in a cell-autonomous manner. Mol Biol Cell. 2014;25(6):916–924. doi: 10.1091/mbc.E13-04-0213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Böhni R, Riesgo-Escovar J, Oldham S, et al. Autonomous control of cell and organ size by CHICO, a drosophila homolog of vertebrate IRS1–4. Cell. 1999;97(7):865–875. doi: 10.1016/s0092-8674(00)80799-0. [DOI] [PubMed] [Google Scholar]
  • 53.Junger MA, Rintelen F, Stocker H, et al. The drosophila forkhead transcription factor FOXO mediates the reduction in cell number associated with reduced insulin signaling. J Biol. 2003;2(3):20. doi: 10.1186/1475-4924-2-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Puig O, Tjian R. Nutrient availability and growth: Regulation of insulin signaling by dFOXO/FOXO1. Cell Cycle. 2006;5(5):503–505. doi: 10.4161/cc.5.5.2501. [DOI] [PubMed] [Google Scholar]
  • 55.Kramer JM, Davidge JT, Lockyer JM, Staveley BE. Expression of drosophila FOXO regulates growth and can phenocopy starvation. BMC Dev Biol. 2003;3:5. doi: 10.1186/1471-213X-3-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Herranz H, Perez L, Martin FA, Milan M. A wingless and notch double-repression mechanism regulates G1-S transition in the drosophila wing. EMBO J. 2008;27(11):1633–1645. doi: 10.1038/emboj.2008.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Quinn LM, Secombe J, Hime GR. Myc in stem cell behaviour: Insights from drosophila. Adv Exp Med Biol. 2013;786:269–285. doi: 10.1007/978-94-007-6621-1_15. [DOI] [PubMed] [Google Scholar]
  • 58.Gallant P. Advances in cancer research. Vol. 103. Academic Press; 2009. Chapter 5 drosophila myc; pp. 111–144. http://dx.doi.org/10.1016/S0065-230X(09)03005-X. [DOI] [PubMed] [Google Scholar]

RESOURCES